Effective Suppression of Vancomycin‐ResistantEnterococcusSpecies in Asymptomatic Gastrointestinal Carriers by a Novel Glycolipodepsipeptide, Ramoplanin

Authors:
  • RGRamoplanin VRE2 Clinical Study Group
    Ramoplanin VRE2 Clinical Study Group

Abstract
Nosocomial bloodstream infections due to vancomycin-resistant enterococci (VRE) are associated with increased morbidity rates, mortality rates, and h

This publication has 30 references indexed in Scilit: